Solvias NL (formerly Cergentis)

Solvias NL, formerly known as Cergentis is a trusted genomics-focused biotech company providing services and in-house solutions based on its proprietary genomic analysis platform to all leading biopharmaceutical companies and renowned research institutes. With our widely published and recognized genetic analyses, we support our global customer base in the characterization and QC of their genetically engineered models, biopharmaceutical cell line development and cell- and gene therapy products. By helping to de-risk R&D program decisions, minimizing time-to-clinic, providing objective genomic evidence for regulators, and supporting patient safety, we aim to support biopharmaceutical medicine development programs worldwide. For more information, visit solvias.com...

Complete gene sequencing,targeted gene sequencing,translocation detection,next generation sequencing,quality control,transgenic animal models,cho cells,cell line characterization,clonality assurance,genetic stability analysis,transgene sequencing,integration site sequencing,gene fusion detection,cell therapy,gene therapy,atmp,genetic engineering,genetic quality control,and solutions provider

Solvias nl (formerly cergentis) operates in the Biotechnology research industry.

Solvias nl (formerly cergentis)'s revenue is 11m - 100m

Solvias nl (formerly cergentis) has 11 - 50 employees.